2. Academic Validation
  3. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors

Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors

  • J Med Chem. 2005 Feb 24;48(4):905-8. doi: 10.1021/jm049363q.
Alice L Bodnar 1,  Luz A Cortes-Burgos,  Karen K Cook,  Dac M Dinh,  Vincent E Groppi,  Mihaly Hajos,  Nicole R Higdon,  William E Hoffmann,  Raymond S Hurst,  Jason K Myers,  Bruce N Rogers,  Theron M Wall,  Mark L Wolfe,  Erik Wong
Affiliations

Affiliation

  • 1 Department of Neuroscience, Global Research and Development, Pfizer Inc., Groton, CT, USA.
PMID: 15715459 DOI: 10.1021/jm049363q
Abstract

A library of benzamides was tested for alpha7 nicotinic acetylcholine receptor (nAChR) agonist activity using a chimeric receptor in a functional, cell-based, high-throughput assay. From this library, quinuclidine benzamides were found to have alpha7 nAChR Agonist activity. The SAR diverged from the activity of this compound class verses the 5-HT(3) receptor, a structural homologue of the alpha7 nAChR. PNU-282987, the most potent compound from this series, was also shown to open native alpha7 nAChRs in cultured rat neurons and to reverse an amphetamine-induced gating deficit in rats.

Figures
Products